Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer U.S. Savings Plan by Year
U.S. Savings Plan — Pfizer Inc. common stock held by plan ($M) ($M)
Pfizer U.S. Savings Plan: $939M in FY2025, down 11.3% from a year earlier. That is the lowest of the 9 years on record here.
Latest, FY2025
939
Period ended Dec 31, 2025
Change on a year earlier
-11.3%
1,059 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below
Where the FY2025 figure comes from
“|| Pfizer Inc. common stock | $ | 938,916 | $ | 1,058,778”
Source: Form 11-K (Pfizer Savings Plan) (pfe-20260615.htm, filed 2026-06-16) ↗
Reported in Form 11-K — Pfizer Savings Plan (U.S.).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Pfizer U.S. Savings Plan ($M), annual FY2017–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/plan-us-pfe-stock
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.